Previous 10 | Next 10 |
Gainers: Audentes Therapeutics (NASDAQ: BOLD ) +105% . More news on: Audentes Therapeutics, Inc., ViewRay, Inc., Outlook Therapeutics, Inc., Stocks on the move, Read more ...
35-Year Agribusiness Veteran to Strengthen Agronomy Team & Support Market Entry into New Crops Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healthy food ingredients, has appointed Vince Restucci in a newly created role as Vice President of Agronomy Ser...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch t...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healthy food ingredients, has been invited to participate in the following investor conferences during the months of November and December 2019: Morgan Stanley Global Chemicals, Agriculture and Packaging Confere...
Calyxt, Inc. (CLXT) Q3 2019 Earnings Conference Call November 6, 2019 04:30 pm ET Company Participants Chris Tyson - Managing Director, MZ North America, Investor Relations Jim Blome - Chief Executive Officer Bill Koschak - Chief Financial Officer Travis Frey - Chief Technology...
Calyxt (NASDAQ: CLXT ): Q3 GAAP EPS of -$0.32 misses by $0.02 . More news on: Calyxt, Inc., Earnings news and commentary, Energy stocks news, , Read more ...
Q3 High Oleic Soybean Product Revenue of $3 Million Represents Highest in Company History Reiterates 2019 Annual Revenue Guidance of $7 Million to $8 Million Operational Savings Expected to Extend Cash Runway to Mid-2021 Over 70,000 2020 Acres Contracted as of October 31, 201...
Calyxt, Inc. (NASDAQ: CLXT), a plant-based breeding and technology platform company, will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2019. A press release detailing these results will be is...
The following slide deck was published by Calyxt, Inc. in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
Shares of Calyxt, Inc. (NASDAQ: CLXT) traded at a new 52-week high today and are currently trading at $5.4. So far today, approximately 55,181 shares have been exchanged, as compared to an average 30-day volume of 89,248 shares. Calyxt, Inc., a synthetic biology company, engages in delivering...
Calyxt Announces Stockholder Approval of Merger With Cibus PR Newswire -- Calyxt Announces 1-for-5 Reverse Stock Split of Common Stock -- ROSEVILLE, Minn. , May 19, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announc...
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update PR Newswire —P roposed merger with Cibus Global Expected to Close in Q2 2023 — —1-for-10 reverse stock split executed— —Current customer...